Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo.
1. It has been hypothesized that 5-HT1A autoreceptor antagonists may enhance the therapeutic efficacy of SSRIs and other antidepressants. Although early clinical trials with the beta-adrenoceptor/5-HT1 ligand, pindolol, were promising, the results of recent more extensive trials have been contradict...
Asıl Yazarlar: | Clifford, E, Gartside, SE, Umbers, V, Cowen, P, Hajós, M, Sharp, T |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1998
|
Benzer Materyaller
-
Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Yazar:: Gartside, SE, ve diğerleri
Baskı/Yayın Bilgisi: (1999) -
Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?
Yazar:: Rabiner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2004) -
Attenuation of preferential occupancy of 5-HT1A autoreceptors by pindolol in depressed patients: effect of SSRIs or an endophenotype of the depressed state?
Yazar:: Rabiner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons.
Yazar:: Gartside, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2000) -
Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo.
Yazar:: Gartside, SE, ve diğerleri
Baskı/Yayın Bilgisi: (1992)